Michael C. Hewitt

Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria

Louis Schofield, Michael C. Hewitt, Krystal J. Evans et al. · Nature · 2002 · 485 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain

Ballachanda N. Devaiah, Brian A. Lewis, Natasha Cherman et al. · Proceedings of the National Academy of Sciences · 2012 · 378 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials

Brian K. Albrecht, Victor Gehling, Michael C. Hewitt et al. · Journal of Medicinal Chemistry · 2016 · 215 citations · Full text

Medicine, Oncology, Pharmacology +15

Rapid Synthesis of a Glycosylphosphatidylinositol-Based Malaria Vaccine Using Automated Solid-Phase Oligosaccharide Synthesis

Michael C. Hewitt, Daniel A. Snyder, Peter H. Seeberger · Journal of the American Chemical Society · 2002 · 134 citations

Pharmacy, Biochemistry, Pharmaceutics +17

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

Terry D. Crawford, Vickie Tsui, E. Megan Flynn et al. · Journal of Medicinal Chemistry · 2016 · 118 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12